{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:32:08Z","timestamp":1775230328782,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92259104"],"award-info":[{"award-number":["92259104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to develop and validate a deep learning-based system using pre-therapy computed tomography (CT) images to detect epidermal growth factor receptor (EGFR)-mutant status in patients with non-small cell lung cancer (NSCLC) and predict the prognosis of advanced-stage patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors (TKI). This retrospective, multicenter study included 485 patients with NSCLC from four hospitals. Of them, 339 patients from three centers were included in the training dataset to develop an EfficientNetV2-L-based model (EME) for predicting EGFR-mutant status, and the remaining patients were assigned to an independent test dataset. EME semantic features were extracted to construct an EME-prognostic model to stratify the prognosis of EGFR-mutant NSCLC patients receiving EGFR-TKI. A comparison of EME and radiomics was conducted. Additionally, we included patients from The Cancer Genome Atlas lung adenocarcinoma dataset with both CT images and RNA sequencing data to explore the biological associations between EME score and EGFR-related biological processes. EME obtained an area under the curve (AUC) of 0.907 (95% CI 0.840\u20130.926) on the test dataset, superior to the radiomics model (<jats:italic>P<\/jats:italic>\u2009=\u20090.007). The EME and radiomics fusion model showed better (AUC, 0.941) but not significantly increased performance (<jats:italic>P<\/jats:italic>\u2009=\u20090.895) compared with EME. In prognostic stratification, the EME-prognostic model achieved the best performance (C-index, 0.711). Moreover, the EME-prognostic score showed strong associations with biological pathways related to EGFR expression and EGFR-TKI efficacy. EME demonstrated a non-invasive and biologically interpretable approach to predict EGFR status, stratify survival prognosis, and correlate biological pathways in patients with NSCLC.<\/jats:p>","DOI":"10.1007\/s10278-024-01022-z","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T22:02:10Z","timestamp":1708034530000},"page":"1086-1099","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EfficientNet-Based System for Detecting EGFR-Mutant Status and Predicting Prognosis of Tyrosine Kinase Inhibitors in Patients with NSCLC"],"prefix":"10.1007","volume":"37","author":[{"given":"Nan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3355-9930","authenticated-orcid":false,"given":"Jiangdian","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"1","key":"1022_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A: Cancer statistics, 2022. CA Cancer J Clin 72(1):7-33, 2022.","journal-title":"CA Cancer J Clin"},{"issue":"7689","key":"1022_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C: The biology and management of non-small cell lung cancer. Nature 553(7689):446-54, 2018.","journal-title":"Nature"},{"issue":"11","key":"1022_CR3","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1158\/1055-9965.EPI-14-0493","volume":"23","author":"I Cheng","year":"2014","unstructured":"Cheng I, Le GM, Noone AM, Gali K, Patel M, Haile RW, Wakelee HA, Gomez SL: Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010. Cancer Epidemiol Biomarkers Prev 23(11):2250-65, 2014.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1022_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3322\/caac.21552","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, Mak RH, Tamimi RM, Tempany CM, Swanton C, Hoffmann U, Schwartz LH, Gillies RJ, Huang RY, Aerts H: Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin 69(2):127-57, 2019.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1022_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jtho.2016.09.001","volume":"12","author":"MB Barnet","year":"2017","unstructured":"Barnet MB, O'Toole S, Horvath LG, Selinger C, Yu B, Ng CC, Boyer M, Cooper WA, Kao S: EGFR-Co-Mutated Advanced NSCLC and Response to\u00a0EGFR Tyrosine Kinase Inhibitors. J Thorac Oncol 12(3):585-90, 2017.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1022_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","volume":"11","author":"T Mitsudomi","year":"2010","unstructured":"Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, Asami K, Katakami N, Takada M, Yoshioka H, Shibata K, Kudoh S, Shimizu E, Saito H, Toyooka S, Nakagawa K, Fukuoka M: Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 11(2):121-8, 2010.","journal-title":"Lancet Oncol"},{"issue":"3","key":"1022_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Mu\u00f1oz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L: Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13(3):239-46, 2012.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1022_CR8","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2589-7500(22)00024-3","volume":"4","author":"S Wang","year":"2022","unstructured":"Wang S, Yu H, Gan Y, Wu Z, Li E, Li X, Cao J, Zhu Y, Wang L, Deng H, Xie M, Wang Y, Ma X, Liu D, Chen B, Tian P, Qiu Z, Xian J, Ren J, Wang K, Wei W, Xie F, Li Z, Wang Q, Xue X, Liu Z, Shi J, Li W, Tian J: Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study. Lancet Digit Health 4(5):e309-e19, 2022.","journal-title":"Lancet Digit Health"},{"issue":"11","key":"1022_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41571-018-0081-4","volume":"15","author":"G Recondo","year":"2018","unstructured":"Recondo G, Facchinetti F, Olaussen KA, Besse B, Friboulet L: Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Nat Rev Clin Oncol 15(11):694-708, 2018.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"1022_CR10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2214\/AJR.14.14147","volume":"205","author":"E Ozkan","year":"2015","unstructured":"Ozkan E, West A, Dedelow JA, Chu BF, Zhao W, Yildiz VO, Otterson GA, Shilo K, Ghosh S, King M, White RD, Erdal BS: CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. AJR Am J Roentgenol 205(5):1016-25, 2015.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"1022_CR11","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.21037\/jtd.2018.11.03","volume":"10","author":"XY Li","year":"2018","unstructured":"Li XY, Xiong JF, Jia TY, Shen TL, Hou RP, Zhao J, Fu XL: Detection of epithelial growth factor receptor (EGFR) mutations on CT images of patients with lung adenocarcinoma using radiomics and\/or multi-level residual convolutionary neural networks. J Thorac Dis 10(12):6624-35, 2018.","journal-title":"J Thorac Dis"},{"issue":"11","key":"1022_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002711","volume":"15","author":"A Hosny","year":"2018","unstructured":"Hosny A, Parmar C, Coroller TP, Grossmann P, Zeleznik R, Kumar A, Bussink J, Gillies RJ, Mak RH, Aerts H: Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. PLoS Med 15(11):e1002711, 2018.","journal-title":"PLoS Med"},{"issue":"1","key":"1022_CR13","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1038\/s41467-020-19116-x","volume":"11","author":"W Mu","year":"2020","unstructured":"Mu W, Jiang L, Zhang J, Shi Y, Gray JE, Tunali I, Gao C, Sun Y, Tian J, Zhao X, Sun X, Gillies RJ, Schabath MB: Non-invasive decision support for NSCLC treatment using PET\/CT radiomics. Nat Commun 11(1):5228, 2020.","journal-title":"Nat Commun"},{"key":"1022_CR14","doi-asserted-by":"publisher","first-page":"5499385","DOI":"10.1155\/2021\/5499385","volume":"2021","author":"C Wang","year":"2021","unstructured":"Wang C, Xu X, Shao J, Zhou K, Zhao K, He Y, Li J, Guo J, Yi Z, Li W: Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images. J Oncol 2021:5499385, 2021.","journal-title":"J Oncol"},{"issue":"3","key":"1022_CR15","doi-asserted-by":"publisher","first-page":"1800986","DOI":"10.1183\/13993003.00986-2018","volume":"53","author":"S Wang","year":"2019","unstructured":"Wang S, Shi J, Ye Z, Dong D, Yu D, Zhou M, Liu Y, Gevaert O, Wang K, Zhu Y, Zhou H, Liu Z, Tian J: Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning. Eur Respir J 53(3):1800986, 2019.","journal-title":"Eur Respir J"},{"key":"1022_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101541","volume":"51","author":"K Deng","year":"2022","unstructured":"Deng K, Wang L, Liu Y, Li X, Hou Q, Cao M, Ng NN, Wang H, Chen H, Yeom KW, Zhao M, Wu N, Gao P, Shi J, Liu Z, Li W, Tian J, Song J: A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study. EClinicalMedicine 51:101541, 2022.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"1022_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5842","volume":"3","author":"Y She","year":"2020","unstructured":"She Y, Jin Z, Wu J, Deng J, Zhang L, Su H, Jiang G, Liu H, Xie D, Cao N, Ren Y, Chen C: Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival. JAMA Netw Open 3(6):e205842, 2020.","journal-title":"JAMA Netw Open"},{"issue":"Suppl 2","key":"1022_CR18","doi-asserted-by":"publisher","first-page":"29s","DOI":"10.2967\/jnumed.118.220590","volume":"60","author":"F Nensa","year":"2019","unstructured":"Nensa F, Demircioglu A, Rischpler C: Artificial Intelligence in Nuclear Medicine. J Nucl Med 60(Suppl 2):29s-37s, 2019.","journal-title":"J Nucl Med"},{"key":"1022_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.inffus.2021.07.016","volume":"77","author":"G Yang","year":"2022","unstructured":"Yang G, Ye Q, Xia J: Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: A mini-review, two showcases and beyond. Inf Fusion 77:29-52, 2022.","journal-title":"Inf Fusion"},{"key":"1022_CR20","doi-asserted-by":"crossref","unstructured":"Madani A, Arnaout R, Mofrad M, Arnaout R: Fast and accurate view classification of echocardiograms using deep learning. NPJ Digit Med 1(1):1-6, 2018.","DOI":"10.1038\/s41746-017-0013-1"},{"key":"1022_CR21","unstructured":"Tan M, Le QV. EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks. International conference on machine learning, PMLR May 01, 2019:6105\u201314, 2019."},{"key":"1022_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2022.119212","volume":"213","author":"LH Nguyen","year":"2023","unstructured":"Nguyen LH, Pham NT, Do VH, Nguyen LT, Nguyen TT, Nguyen H, Nguyen ND, Nguyen TT, Nguyen SD, Bhatti A, Lim CP: Fruit-CoV: An efficient vision-based framework for speedy detection and diagnosis of SARS-CoV-2 infections through recorded cough sounds. Expert Syst Appl 213:119212, 2023.","journal-title":"Expert Syst Appl"},{"key":"1022_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2022.110527","volume":"156","author":"H Wang","year":"2022","unstructured":"Wang H, Liu Y, Xu N, Sun Y, Fu S, Wu Y, Liu C, Cui L, Liu Z, Chang Z, Li S, Deng K, Song J: Development and validation of a deep learning model for survival prognosis of transcatheter arterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma. Eur J Radiol 156:110527, 2022.","journal-title":"Eur J Radiol"},{"issue":"4","key":"1022_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/cncy.22669","volume":"131","author":"M Hirokawa","year":"2022","unstructured":"Hirokawa M, Niioka H, Suzuki A, Abe M, Arai Y, Nagahara H, Miyauchi A, Akamizu T: Application of deep learning as an ancillary diagnostic tool for thyroid FNA cytology. Cancer Cytopathol 131(4):217-25, 2022.","journal-title":"Cancer Cytopathol"},{"issue":"7878","key":"1022_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","volume":"597","author":"JP Robichaux","year":"2021","unstructured":"Robichaux JP, Le X, Vijayan RSK, Hicks JK, Heeke S, Elamin YY, Lin HY, Udagawa H, Skoulidis F, Tran H, Varghese S, He J, Zhang F, Nilsson MB, Hu L, Poteete A, Rinsurongkawong W, Zhang X, Ren C, Liu X, Hong L, Zhang J, Diao L, Madison R, Schrock AB, Saam J, Raymond V, Fang B, Wang J, Ha MJ, Cross JB, Gray JE, Heymach JV: Structure-based classification predicts drug response in EGFR-mutant NSCLC. Nature 597(7878):732-7, 2021.","journal-title":"Nature"},{"issue":"2","key":"1022_CR26","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u201347, 2009.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1022_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, Gerig G: User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31(3):1116-28, 2006.","journal-title":"Neuroimage"},{"issue":"11","key":"1022_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206108","volume":"13","author":"TH Dou","year":"2018","unstructured":"Dou TH, Coroller TP, van Griethuysen JJM, Mak RH, Aerts H: Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One 13(11):e0206108, 2018.","journal-title":"PLoS One"},{"key":"1022_CR29","doi-asserted-by":"crossref","unstructured":"Chen Q, Shao J, Xue T, Peng H, Li M, Duan S, Feng F: Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Eur Radiol 33(2):947-958, 2023","DOI":"10.1007\/s00330-022-09109-3"},{"issue":"3","key":"1022_CR30","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00330-022-09174-8","volume":"33","author":"L Wu","year":"2022","unstructured":"Wu L, Lou X, Kong N, Xu M, Gao C: Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review. Eur Radiol 33(3):2105-17, 2022.","journal-title":"A systematic review. Eur Radiol"},{"key":"1022_CR31","unstructured":"Tan M, Le Q, editors. Efficientnetv2: Smaller models and faster training. International conference on machine learning PMLR, 2021:10096-10106, 2021"},{"key":"1022_CR32","unstructured":"Akaike H, editor. Information theory as an extension of the maximum likelihood principle.  In Proc. 2nd int. symp. on information theory: pp 267-281, 1973."},{"issue":"21","key":"1022_CR33","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL: X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252-9, 2004.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"1022_CR34","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","volume":"77","author":"JJM van Griethuysen","year":"2017","unstructured":"van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H: Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77(21):e104-e7, 2017.","journal-title":"Cancer Res"},{"issue":"2","key":"1022_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s11263-019-01228-7","volume":"128","author":"RR Selvaraju","year":"2020","unstructured":"Selvaraju RR, Cogswell M, Das A, Vedantam R, Parikh D, Batra D: Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization. International Journal of Computer Vision 128(2):336-59, 2020.","journal-title":"International Journal of Computer Vision"},{"issue":"9","key":"1022_CR36","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.annonc.2021.06.007","volume":"32","author":"S Foersch","year":"2021","unstructured":"Foersch S, Eckstein M, Wagner DC, Gach F, Woerl AC, Geiger J, Glasner C, Schelbert S, Schulz S, Porubsky S, Kreft A, Hartmann A, Agaimy A, Roth W: Deep learning for diagnosis and survival prediction in soft tissue sarcoma. Ann Oncol 32(9):1178-87, 2021.","journal-title":"Ann Oncol"},{"issue":"3","key":"1022_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837-45, 1988.","journal-title":"Biometrics"},{"key":"1022_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101934","volume":"58","author":"SF Tsai","year":"2023","unstructured":"Tsai SF, Yang CT, Liu WJ, Lee CL: Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine 58:101934, 2023.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"1022_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","volume":"76","author":"HY Kim","year":"2022","unstructured":"Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, Seo YS, Lee HA, Park SY, Lim YS, Jang ES, Yoon EL, Kim HS, Kim SE, Ahn SB, Shim JJ, Jeong SW, Jung YJ, Sohn JH, Cho YK, Jun DW, Dalekos GN, Idilman R, Sypsa V, Berg T, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Janssen HLA, Jang MJ, Lee YB, Kim YJ, Yoon JH, Papatheodoridis GV, Lee JH: An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B. J Hepatol 76(2):311-8, 2022.","journal-title":"J Hepatol"},{"issue":"9","key":"1022_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/jnci\/dji112","volume":"97","author":"F Cappuzzo","year":"2005","unstructured":"Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, Haney J, Witta S, Danenberg K, Domenichini I, Ludovini V, Magrini E, Gregorc V, Doglioni C, Sidoni A, Tonato M, Franklin WA, Crino L, Bunn PA, Jr., Varella-Garcia M: Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 97(9):643-55, 2005.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1022_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1056\/NEJMoa050736","volume":"353","author":"MS Tsao","year":"2005","unstructured":"Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA: Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med 353(2):133-44, 2005.","journal-title":"N Engl J Med"},{"key":"1022_CR42","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.biophys.37.032807.125829","volume":"37","author":"KM Ferguson","year":"2008","unstructured":"Ferguson KM: Structure-based view of epidermal growth factor receptor regulation. Annu Rev Biophys 37:353-73, 2008.","journal-title":"Annu Rev Biophys"},{"issue":"12","key":"1022_CR43","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1023\/A:1008209720526","volume":"8","author":"BR Voldborg","year":"1997","unstructured":"Voldborg BR, Damstrup L, Spang-Thomsen M, Poulsen HS: Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol 8(12):1197-206, 1997.","journal-title":"Ann Oncol"},{"issue":"5676","key":"1022_CR44","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304(5676):1497-500, 2004.","journal-title":"Science"},{"issue":"36","key":"1022_CR45","doi-asserted-by":"publisher","first-page":"13306","DOI":"10.1073\/pnas.0405220101","volume":"101","author":"W Pao","year":"2004","unstructured":"Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H: EGF receptor gene mutations are common in lung cancers from \"never smokers\" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 101(36):13306-11, 2004.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1022_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.894323","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Xu P, Li M, Wang M, Peng M, Zhang Y, Wu T, Chu W, Wang K, Meng H, Zhang L: PET\/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs. Front Oncol 12:894323, 2022.","journal-title":"Front Oncol"},{"key":"1022_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.897597","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, Song F, Zhang P, Fan G, Zhang T, Zhao X, Ma C, Sun Y, Song X, Pu H, Liu F, Zhang G: Prediction of EGFR Mutation Status in Non-Small Cell Lung Cancer Based on Ensemble Learning. Front Pharmacol 13:897597, 2022.","journal-title":"Front Pharmacol"},{"key":"1022_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737368","volume":"11","author":"M Astaraki","year":"2021","unstructured":"Astaraki M, Yang G, Zakko Y, Toma-Dasu I, Smedby \u00d6, Wang C: A Comparative Study of Radiomics and Deep-Learning Based Methods for Pulmonary Nodule Malignancy Prediction in Low Dose CT Images. Front Oncol 11:737368, 2021.","journal-title":"Front Oncol"},{"key":"1022_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.898529","volume":"13","author":"W Huang","year":"2022","unstructured":"Huang W, Wang J, Wang H, Zhang Y, Zhao F, Li K, Su L, Kang F, Cao X: PET\/CT Based EGFR Mutation Status Classification of NSCLC Using Deep Learning Features and Radiomics Features. Front Pharmacol 13:898529, 2022.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1022_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1109\/JPROC.2019.2950187","volume":"108","author":"HM Whitney","year":"2020","unstructured":"Whitney HM, Li H, Ji Y, Liu P, Giger ML: Comparison of Breast MRI Tumor Classification Using Human-Engineered Radiomics, Transfer Learning From Deep Convolutional Neural Networks, and Fusion Methods. Proc IEEE Inst Electr Electron Eng 108(1):163-77, 2020.","journal-title":"Proc IEEE Inst Electr Electron Eng"},{"issue":"12","key":"1022_CR51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30442","volume":"3","author":"J Song","year":"2020","unstructured":"Song J, Wang L, Ng NN, Zhao M, Shi J, Wu N, Li W, Liu Z, Yeom KW, Tian J: Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer. JAMA Netw Open 3(12):e2030442, 2020.","journal-title":"JAMA Netw Open"},{"key":"1022_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.media.2017.07.005","volume":"42","author":"G Litjens","year":"2017","unstructured":"Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M, van der Laak J, van Ginneken B, S\u00e1nchez CI: A survey on deep learning in medical image analysis. Med Image Anal 42:60-88, 2017.","journal-title":"Med Image Anal"},{"key":"1022_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2020.110190","volume":"140","author":"H Panwar","year":"2020","unstructured":"Panwar H, Gupta PK, Siddiqui MK, Morales-Menendez R, Bhardwaj P, Singh V: A deep learning and grad-CAM based color visualization approach for fast detection of COVID-19 cases using chest X-ray and CT-Scan images. Chaos Solitons Fractals 140:110190, 2020.","journal-title":"Chaos Solitons Fractals"},{"issue":"11","key":"1022_CR54","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1158\/1078-0432.CCR-18-2495","volume":"25","author":"Y Xu","year":"2019","unstructured":"Xu Y, Hosny A, Zeleznik R, Parmar C, Coroller T, Franco I, Mak RH, Aerts H: Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging. Clin Cancer Res 25(11):3266-75, 2019.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-024-01022-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:11:04Z","timestamp":1718197864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-024-01022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["1022"],"URL":"https:\/\/doi.org\/10.1007\/s10278-024-01022-z","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the First Hospital of China Medical University (No. AF-SOP-07\u20131).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was waived by the institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have consented to the submission of the manuscript and the authors have obtained consent for publication for the content covered in the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}